In 2025, Ozempic was approved by the US Food and Drug Administration (FDA) to reduce the risk of worsening kidney disease and kidney failure in people with type 2 diabetes
Most physicians recommend choosing one pathway: phentermine (short-term, stimulant-based) or GLP-1 therapy (sustained, non-stimulant)
Hes a real guy. As incredible as his story is just getting to Cal Baptist undersized, academic issues, a bad experience at a Las Vegas prep school, nearly quitting basketball during the pandemic, spending two years at San Bernardino Community College the more remarkable part might be that he stayed there in an era of seven-figure NIL and revenue-sharing payouts
We assessed the matching based on the standardized mean difference and variance ratio, including polynomials up to degree two (for continuous variables), and all two-way interactions (Supplementary File S1)
Heather Fagnant, RDN Heather Fagnant is a Registered Dietitian with Care Access and has more than a decade of experience with nutrition and research